Medicare GLP-1 Coverage 2026: What Changed
Understanding Medicare's expanded coverage of GLP-1 medications for weight management in 2026. Eligibility criteria, covered medications, costs, and how to access benefits.
More on GLP-1 News
Historic Change
For the first time, Medicare is covering anti-obesity medications for weight management—not just diabetes. This change affects approximately 65 million Medicare beneficiaries, many of whom have been paying full out-of-pocket costs for GLP-1 medications.
What Changed and Why It Matters
Historically, Medicare was prohibited from covering anti-obesity medications under Part D. This exclusion dated back to 2003, when the Medicare Modernization Act specifically carved out weight loss drugs from coverage. For over two decades, Medicare beneficiaries who wanted GLP-1 medications for weight loss had to pay entirely out of pocket—often over $1,000 per month.
The legislative change reflects growing scientific consensus that obesity is a chronic disease requiring medical treatment, not a lifestyle choice. With GLP-1 medications demonstrating not just weight loss but cardiovascular risk reduction, kidney protection, and metabolic improvements, the case for coverage became overwhelming.
CBO estimates suggest that covering GLP-1 medications under Medicare will cost approximately $35 billion over ten years, but may save significantly more through reduced hospitalizations for heart attacks, strokes, diabetes complications, and joint replacements.
Eligibility and Coverage Details
Who qualifies
- Medicare Part D enrollees with BMI of 30 or higher
- BMI of 27+ with at least one weight-related comorbidity
- Documentation of medical necessity from prescribing provider
- Some plans may require prior authorization
What is covered
- FDA-approved anti-obesity medications (plan formulary applies)
- Standard Part D cost-sharing applies (deductible, copay, coverage gap)
- Out-of-pocket maximum applies under the Inflation Reduction Act
- Compounded medications are generally not covered
Understanding Your Costs
Under the Inflation Reduction Act, Medicare Part D out-of-pocket costs are capped at $2,000 per year for all medications combined. This means that even if GLP-1 medications are placed on a specialty tier with high cost-sharing, your total annual out-of-pocket spending for all prescriptions will not exceed $2,000.
Estimated Monthly Costs (examples)
How to Reduce Costs
- Apply for Low-Income Subsidy (Extra Help)
- Use manufacturer copay assistance programs
- Compare plans during open enrollment
- Ask about preferred pharmacy networks
How to Get Started
Step 1: Schedule an appointment with your provider to discuss GLP-1 treatment and establish medical necessity documentation.
Step 2: Check your Part D plan formulary to see which GLP-1 medications are covered and at what tier.
Step 3: Your provider submits a prescription and any required prior authorization with supporting documentation.
Step 4: Fill your prescription at a network pharmacy. Ask about preferred pharmacies for lower cost-sharing.
Step 5: If denied, file an appeal. Medicare appeals have specific timelines and processes that your provider can help navigate.
Medical Disclaimer: This article is for educational purposes only. Medicare coverage details vary by plan and change annually. Contact Medicare (1-800-MEDICARE) or your plan directly for specific coverage information applicable to your situation.
Frequently Asked Questions
Does Medicare now cover GLP-1 medications for weight loss?
Following the Treat and Reduce Obesity Act provisions, Medicare has expanded coverage for FDA-approved anti-obesity medications, including GLP-1 receptor agonists, under Part D plans. Coverage criteria include a BMI threshold and documented medical necessity.
What are the eligibility requirements?
Generally, Medicare beneficiaries need a BMI of 30 or higher (or 27+ with a weight-related comorbidity like type 2 diabetes, hypertension, or sleep apnea), a documented history of weight management attempts, and a prescribing provider who documents medical necessity.
How much will I pay out of pocket?
Costs vary by Part D plan. With standard coverage, expect a copay or coinsurance during the deductible phase and coverage gap. Low-Income Subsidy (Extra Help) recipients may pay significantly less. Some plans may require step therapy or prior authorization.
Are all GLP-1 medications covered equally?
No. Each Part D plan has its own formulary. Preferred medications typically have lower copays. Some plans may require trying one medication before approving another (step therapy). Check your specific plan's formulary for tier placement and requirements.
Start Your GLP-1 Treatment
Our team helps navigate insurance coverage and find the most affordable option for your GLP-1 treatment.
Get StartedSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).